The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Voznyuk I.A.

Shamalov N.A.

Pirogov National Research Medical University;
Federal Center for Brain Research and Neurotechnologies

Ezhov M.V.

National Medical Research Center of Cardiology

Tikhomirova O.V.

Nikiforov Russian Center of Emergency and Radiation Medicine

Gurevich V.S.

Saint-Petersburg State University;
Mechnikov North-Western State Medical University

Kucherenko S.S.

The L.G. Sokolov Memorial Hospital 122. Federal Medical and Biological Agency

Konovalov G.A.

Joint Stock Company Medsi group

Konstantinov V.O.

Mechnikov North-Western State Medical University

Ershova A.I.

National Medical Research Center for Therapy and Preventive Medicine

Optimization of lipid-lowering therapy in patients after ischemic stroke. Resolution of the Council of Experts

Authors:

Voznyuk I.A., Shamalov N.A., Ezhov M.V., Tikhomirova O.V., Gurevich V.S., Kucherenko S.S., Konovalov G.A., Konstantinov V.O., Ershova A.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6): 152‑161

DOI: 10.17116/jnevro2020120061152

Read: 5596 times

Contact the author
Table of contents

OPTIMIZATION OF LIPID-LOWERING THERAPY IN PATIENTS AFTER ISCHEMIC STROKE. RESOLUTION OF THE COUNCIL OF EXPERTS
OPTIMIZATION OF LIPID-LOWERING THERAPY IN PATIENTS AFTER ISCHEMIC STROKE. RESOLUTION OF THE COUNCIL OF EXPERTS

To cite this article:

Voznyuk IA, Shamalov NA, Ezhov MV, et al. Optimization of lipid-lowering therapy in patients after ischemic stroke. Resolution of the Council of Experts. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6):152‑161. (In Russ.)
https://doi.org/10.17116/jnevro2020120061152

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Approaches to medi­cal reha­bilitation of patients with post-stroke hemianopsia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):20-25
Epileptogenesis and risk factors of symptomatic epileptic seizures in patients with acute cere­brovascular acci­dents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):26-31
Effe­ctiveness of “brain—computer” inte­rfaces with biofeedback in the reha­bilitation of cognitive impairment after a stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):54-60
Features of speech reha­bilitation in various types of post-stroke dysa­rthria. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):61-66
Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):89-97
Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Deme­ntia: Meta-Analysis and Systematic Review. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):86-99
Prediction of restoration of functional acti­vity of pare­tic limbs in patients who have suffered an ischemic stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(3):31-40
Expe­rience of using peri­pheral magnetic stimulation to restore diaphragm function in hemi­paretic patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(4):5-13
Recu­rrent coro­nary events as a persistent challenge in cardiology. The role of PCSK9 inhi­bitors in respect of this issue through the example of a local program implemented in St. Pete­rsburg. Russian Journal of Preventive Medi­cine. 2025;(9):78-86
Distal protection in transcatheter aortic valve implantation: pros and cons. Choice of the patient or preferences of the clinic and surgeon?. Piro­gov Russian Journal of Surgery. 2025;(11-2):12-19
Abstract:

Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients. The algorithm presents the steps for sequential administration of statins, ezetimibe, and PCSK9 inhibitors to achieve target levels of low-density lipoprotein cholesterol.

Keywords:

stroke
statins
PCSK9 inhibitors
cardiovascular death

Authors:

Voznyuk I.A.

Shamalov N.A.

Pirogov National Research Medical University;
Federal Center for Brain Research and Neurotechnologies

Ezhov M.V.

National Medical Research Center of Cardiology

Tikhomirova O.V.

Nikiforov Russian Center of Emergency and Radiation Medicine

Gurevich V.S.

Saint-Petersburg State University;
Mechnikov North-Western State Medical University

Kucherenko S.S.

The L.G. Sokolov Memorial Hospital 122. Federal Medical and Biological Agency

Konovalov G.A.

Joint Stock Company Medsi group

Konstantinov V.O.

Mechnikov North-Western State Medical University

Ershova A.I.

National Medical Research Center for Therapy and Preventive Medicine

Received:

06.05.2020

Accepted:

07.05.2020

Close metadata

References:

  1. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal. 2016;37(42):3232-3245. https://doi.org/10.1093/eurheartj/ehw334
  2. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S. on behalf of the INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761-775.  https://doi.org/10.1016/S0140-6736(16)30506-2
  3. Sergienko IV, Shestakova MV, Boitsov SA, Ametov AS, Antsiferov MB, Kukharchuk VV, Zateishchikov DA, Ezhov MV, Gurevich VS, Galyavich AS, Voevoda MI, Duplyakov DV, Barbarash OL, Khalimov YuSh, Arutyunov GP, Karpov YuA, Bubnova MG, Drozdova LYu, Sonicheva NA, Ansheles AA, Samorodskaya IV, Koziolova NA, Drapkina OM. Extreme risk category in the stratification of cardiovascular complications. Advisory board consensus. Journal of Atherosclerosis and Dyslipidemias. 2018;4(33):8-16. (In Russ.).
  4. Pikula A, Beiser AS, Wang J, Himali JJ, Kelly-Hayes M, Kase CS, Yang Q, Seshadri S, Wolf PA. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study. Neurology. 2015;84(5):472-479.  https://doi.org/10.1212/WNL.0000000000001202
  5. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering — are they clinically relevant? European Heart Journal. 2003;24(3):225-248.  https://doi.org/10.1016/S0195-668X(02)00419-0
  6. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurology. 2009;8(5):453-463.  https://doi.org/10.1016/S1474-4422(09)70058-4
  7. Salvatore T, Morganti R, Marchioli R, De Caterina R. Cholesterol lowering and stroke: no longer room for pleiotropic effects of statins — confirmation from PCSK9 inhibitor studies. American Journal of Medicine. 2020;133(1):95-99.e6.  https://doi.org/10.1016/j.amjmed.2019.06.029
  8. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine. 2006;355(6):549-559.  https://doi.org/10.1056/NEJMoa061894
  9. Welch K. Review of the SPARCL trial and its subanalyses. Current Atherosclerosis Reports. 2009;11:315-321.  https://doi.org/10.1007/s11883-009-0048-0
  10. Flint AC, Conell C, Ren X, Kamel H, Chan SL, Rao VA, Johnston SC. Statin adherence is associated with reduced recurrent stroke risk in patients with or without atrial fibrillation. Stroke. 2017;48(7):1788-1794. https://doi.org/10.1161/STROKEAHA.117.017343
  11. Fang WT, Li HJ, Zhang H, Jiang S. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. British Journal of Clinical Pharmacology. 2012;74(5):744-756.  https://doi.org/10.1111/j.1365-2125.2012.04258.x
  12. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-2375. https://doi.org/10.1001/jama.285.18.2370
  13. Merwick A, Albers GW, Arsava EM, Ay H, Calvet D, Coutts SB, Cucchiara BL, Demchuk AM, Giles MF, Mas JL, Olivot JM, Purroy F, Rothwell PM, Saver JL, Sharma VK, Tsivgoulis G, Kelly PJ. Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment. Stroke. 2013;44(10):2814-2820. https://doi.org/10.1161/STROKEAHA.113.001576
  14. Sabatine MS, Giugliano RP, Pedersen TR. Evolocumab in patients with cardiovascular disease. New England Journal of Medicine. 2017;377(8):785-788.  https://doi.org/10.1056/NEJMc1708587
  15. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. on behalf of the American Heart Association Stroke Council. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):46-110.  https://doi.org/10.1161/STR.0000000000000158
  16. Ahmed N, Audebert H, Turc G, Cordonnier C, Christensen H, Sacco S, Sandset EC, Ntaios G, Charidimou A, Toni D, Pristipino C, Köhrmann M, Kuramatsu JB, Thomalla G, Mikulik R, Ford GA, Martí-Fàbregas J, Fischer U, Thoren M, Lundström E, Rinkel GJ, van der Worp HB, Matusevicius M, Tsivgoulis G, Milionis H, Rubiera M, Hart R, Moreira T, Lantz M, Sjöstrand C, Andersen G, Schellinger P, Kostulas K, Sunnerhagen KS, Keselman B, Korompoki E, Purrucker J, Khatri P, Whiteley W, Berge E, Mazya M, Dippel DW, Mustanoja S, Rasmussen M, Söderqvist AK, Escudero-Martínez I, Steiner T. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11—13 November 2018. European Stroke Journal. 2019;4(4):307-317.  https://doi.org/10.1177/2396987319863606
  17. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2020;41(1):111-188.  https://doi.org/10.1093/eurheartj/ehz455
  18. Zhao Z, Du S, Shen S, Luo P, Ding S, Wang G, Wang L. Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis. Medicine. 2019;98(6):e14400. https://doi.org/10.1097/MD.0000000000014400
  19. Kamstrup P. Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease. Journal of Lipid Research. 2017;58(9):1731-1732. https://doi.org/10.1194/jlr.C079111
  20. Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, Santos RD, Thanassoulis G, Witztum JL, Danthi S, Olive M, Liu L. NHLBI working group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. Journal of the American College of Cardiology. 2018;71(2):177-192.  https://doi.org/10.1016/j.jacc.2017.11.014
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.